DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.

[1]  S. Weitzman,et al.  Mapping of ER gene CpG island methylation-specific polymerase chain reaction. , 1998, Cancer research.

[2]  G. Giles,et al.  The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations , 1998, Cancer.

[3]  R. Yarden,et al.  BRCA1 interacts with components of the histone deacetylase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Pike,et al.  Reduction of BRCA1 expression in sporadic ovarian cancer. , 2000, Gynecologic oncology.

[5]  Alexander Kinev,et al.  BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer , 2000, Cell.

[6]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Herman,et al.  DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. , 2001, Human molecular genetics.

[8]  S. Baylin,et al.  Altered methylation patterns in cancer cell genomes: cause or consequence? , 2002, Cancer cell.

[9]  W. B. Archey,et al.  Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers , 2002, Oncogene.

[10]  G. Germino,et al.  Role of polycystins in renal tubulogenesis. , 2003, Trends in cell biology.

[11]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[12]  J. Satagopan,et al.  A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment , 2003, Breast Cancer Research.

[13]  A. Richardson,et al.  Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors. , 2003, Cancer research.

[14]  M. Ringnér,et al.  Molecular classification of familial non-BRCA1/BRCA2 breast cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Mak,et al.  p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  O. Henegariu,et al.  SGK1, a potential regulator of c-fms related breast cancer aggressiveness , 2004, Clinical & Experimental Metastasis.

[17]  Julian Peto,et al.  Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype , 2005, Clinical Cancer Research.

[18]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[19]  M. Dufau,et al.  Coordinated Changes in DNA Methylation and Histone Modifications Regulate Silencing/Derepression of Luteinizing Hormone Receptor Gene Transcription , 2005, Molecular and Cellular Biology.

[20]  John L Hopper,et al.  Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource , 2006, Breast Cancer Research.

[21]  A. Knudson.  Hereditary cancer: Two hits revisited , 2005, Journal of Cancer Research and Clinical Oncology.

[22]  Clare Stirzaker,et al.  Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band , 2006, Nature Genetics.

[23]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[24]  S. Seal,et al.  A genome wide linkage search for breast cancer susceptibility genes , 2006, Genes, chromosomes & cancer.

[25]  Hidetoshi Shimodaira,et al.  Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..

[26]  Clifford A. Meyer,et al.  Model-based analysis of tiling-arrays for ChIP-chip , 2006, Proceedings of the National Academy of Sciences.

[27]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[28]  Michael B. Stadler,et al.  Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome , 2007, Nature Genetics.

[29]  F. Couch,et al.  Response: Re: Molecular Basis for Estrogen Receptor α Deficiency in BRCA1-Linked Breast Cancer , 2007 .

[30]  Fergus J Couch,et al.  A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. , 2007, American journal of human genetics.

[31]  Christof Niehrs,et al.  Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation , 2007, Nature.

[32]  M. Hidalgo,et al.  Pyrosequencing protocol using a universal biotinylated primer for mutation detection and SNP genotyping , 2007, Nature Protocols.

[33]  Susan J Clark,et al.  Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. , 2007, Human molecular genetics.

[34]  Jacqueline A. Hall,et al.  Identification of Novel High-Frequency DNA Methylation Changes in Breast Cancer , 2007, PloS one.

[35]  James D. Brenton,et al.  Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer , 2008, Human molecular genetics.

[36]  V. Beneš,et al.  Cyclical DNA methylation of a transcriptionally active promoter , 2008, Nature.

[37]  D. Kwiatkowski,et al.  mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. , 2008, Molecular cell.

[38]  A. Chambers,et al.  Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays , 2008, Breast Cancer Research.

[39]  Emmanuel Barillot,et al.  Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells , 2008, Breast Cancer Research.

[40]  B. Cairns,et al.  DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45 , 2008, Cell.

[41]  E. Kubista,et al.  Beta-hCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis? , 2009, Journal of Cancer Research and Clinical Oncology.

[42]  Mark Girolami,et al.  BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression , 2008, PLoS genetics.

[43]  Vladimir Benes,et al.  Transient cyclical methylation of promoter DNA , 2008, Nature.

[44]  M. Fackler,et al.  Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[45]  Taylor Jensen,et al.  Agglomerative epigenetic aberrations are a common event in human breast cancer. , 2008, Cancer research.

[46]  E. Berns,et al.  LH receptor gene expression is essentially absent in breast tumor tissue: Implications for treatment , 2009, Molecular and Cellular Endocrinology.

[47]  Stephen Fox,et al.  Subtypes of familial breast tumours revealed by expression and copy number profiling , 2010, Breast Cancer Research and Treatment.

[48]  W. Barry,et al.  CpG Island Tumor Suppressor Promoter Methylation in Non-BRCA-Associated Early Mammary Carcinogenesis , 2009, Cancer Epidemiology Biomarkers & Prevention.

[49]  J. Peto,et al.  Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients , 2009, Human molecular genetics.